【摘 要】
：
Hepatocellular carcinoma (HCC) is a multi-factor, multi-step, multi-gene and complicated process resulting from the accumulation of sequential genetic and epigenetic alterations.An important change am
【机 构】
：
Department of Pathology,Tangdu Hospital, the Fourth Military Medical University, Xi'an 710038, P.R
【出 处】
：
第十四届全军诊断病理、第八届全军病理技术及第十一届北方四战区病理学术会议
论文部分内容阅读
Hepatocellular carcinoma (HCC) is a multi-factor, multi-step, multi-gene and complicated process resulting from the accumulation of sequential genetic and epigenetic alterations.An important change among them is from precancerous lesions to HCC.However, only few studies have been reported about the sequential genetic changes during hepatocarcinogenesis.To investigate the sequential genetic changes from precancerous lesions to HCC during hepatocarcinogenesis, we observed firstly molecular karyotypes of 10 matched HCC using Affymetrix single-nucleotide polymorphism (SNP) 6.0 arrays, and found chromosomal fragments with high incidence (more than 80%) of loss of heterozygosity (LOH).Then, we selected 28 microsatellite markers at some gene spanning these chromosomal fragments, and examined the frequency of LOH of 128 matched HCC and 43 matched precancerous lesions-nodules of altered hepatocytes (NAH) by a PCR-based analysis.Finally, we investigated the expression of proteins encoded by these genes in HCC, NAH and the surrounding hepatic tissues.The result of Affymetrix SNP6.0 arrays demonstrated that more than 80 % (8/10) cases had chromosomal fragment deletion on 4q13.3-35.1, 8p23.2-21.2, 16q11.2-24.3, and 17p13.3-12.Among 28 microsatellite markers selected, LOH frequencies at D8S262 for NAH and HCC were found to be the highest, 51.2% and 72.7%, respectively The positive rate of its adjacent gene CSMD1 in HCC, NAH, and the surrounding hepatic tissues were 27.3% (35/128), 75% (33/44), and 82% (105/128), respectively.In conclusion, LOH at D8S262 may be associated with an early genetic event of hepatocarcinogenesis, and a predictor for the monitor and prevention of HCC.
其他文献
目的：评价在对学生脊柱侧凸筛查中,与标准测量方法scoliometer相比scoliogauge对躯干不对称测量的有效性.方法：选择上海祟明县8所中小学中的421名学生(23]名男生和190名女生),年龄10至14岁进行了筛选.由两个有5年以上工作经验的医技人员分别测量并读取上胸段的T3,下胸段的T9和腰段的L2scoliometer或scoliogauge的测量值.统计分析两种测量工具在上胸部,
目的 探讨多房性囊性肾细胞癌(multilocular cystic renal cell carcinoma,MCRCC)临床病理特征及诊断要点.方法 收集19例MCRCC的临床病理资料,并与同期诊断的其他肾囊性病变42例(包括单纯性囊肿22例、透明细胞肾细胞癌癌伴广泛囊性变12例、囊性肾瘤1例、管状囊性肾癌2例、多囊肾2例和肾积水1例)进行形态学和免疫组化比较.结果 临床特点：19例患者中男性
The proteolytic part of CK-19, referred to as CYFRA21-1, is detected as a soluble molecule in serum and other body fluids, and it has been measured as a tumor marker in several neoplastic diseases.To
目的：探讨胃腺癌中CD44和EpCAM的表达及其临床病理意义.方法：采用免疫组化染色SP法,对60例胃腺癌,10例正常胃标本和20例腺瘤的胃黏膜进行CD44和EpCAM的检测.结果：CD44和EpCAM在正常胃粘膜、腺瘤和腺癌中的表达强度依次增强(rs=0.646,p＜0.01；rs=0.495,p＜0.01).在胃腺癌中,CD44的表达强度与性别、浸润深度、淋巴结转移有关,与分化程度呈正相关(r
目的：探讨CD44+/EpCAM+细胞在正常胃粘膜、腺瘤及胃腺癌中的表达数量、分布位置及与胃腺癌病理参数间的关系。方法：应用常规HE染色、免疫组织化学染色及免疫组织化学双重染色方法，定位CD44和EpCAM双阳性细胞，并在HE切片的对应位置上观察其数量、形态特征、分布位置。结果：CD44+/EpCAM+细胞在正常胃粘膜中几乎不表达，胃腺瘤中极少量的表达，在胃腺癌中呈低表达，双阳性细胞的数量占肿瘤总
目的：探讨骨髓间充质干细胞表面分子CD166和CD271在正常胃粘膜、腺瘤及胃腺癌中的表达,初步探讨二者是否可以作为胃癌干细胞的标志物.方法：采用免疫组化染色SP法,对60例胃腺癌,10例正常胃标本和20例腺瘤的胃黏膜进行了骨髓间充质干细胞表面分子CD166和CD271的检测.结果：(1) CD166在正常胃粘膜、不典型增生和胃癌中的表达逐渐降低,表达强度与胃癌的分化程度成正相关(rs=0.597
目的 研究Hp与P53、P63表达在胃癌临床病理特征的关系.方法 应用免疫组化技术检测人胃癌组织芯片144芯中Hp、P53和P63的表达.结果 144例胃癌标本中P53阳性表达80例(55.6％),P63阳性表达53例(36.8％),Hp阳性表达94例(65.3％).P53表达与胃癌组织学分型、病理分级和淋巴结转移有关(P＜0.05),与肿瘤部位及浸润深度无关(P＞0.05)； P63在低分化腺癌
目的：探讨皮肤气球状细胞痣的病理诊断及鉴别诊断。 方法对1例皮肤气球状细胞痣,应用免疫组化S-P (streptavidin-perosidase)法观察,进行临床病理分析。 结果皮肤组织真皮内见胞浆透亮的细胞排列成大小不等由胶原纤维分隔的小叶,痣细胞绝大部分为体积较大、胞质丰富且呈透明状或细颗粒状气球状痣细胞。胞核小而圆,大小一致,多位于细胞的中央,无异型性及核分裂像。免疫组化染色提示气球状痣细
目的：了解2000年 ～2012年来我院结核病病理外检检出情况、病变组织抗酸染色阳性率及临床初诊与病理诊断相符情况.方法同顾性分析近1 3年我院病理诊断结核患者病理资料.结果2131例结核病例中男1130例,女1001例,其中肺结核913例(男556例,女357例),肺外结核1218例(男574例,女644例).2008年～2012年期间与2000年～2007年期问相比较,20～岁年龄组结核患者构